Document is current
Any future updates will be listed below
-
Authors
Compaoré, Yves Daniel http://orcid.org/0000-0001-8848-2187
Zongo, Issaka
Somé, Anyirékun F.
Barry, Nouhoun
Nikiéma, Frederick
Kaboré, Talato N.
Ouattara, Aminata
Kabré, Zachari
Wermi, Kadidiatou
Zongo, Moussa
Yerbanga, Rakiswende S.
Sagara, Issaka
Djimdé, Abdoulaye
Ouédraogo, Jean Bosco
- License Information
-
More Information
Article History
Received: 20 August 2020
Accepted: 15 January 2021
First Online: 29 January 2021
Ethics approval and consent to participate
: This secondary analysis was in line with the main study objectives and did not require further approval from ethics committee. The original study protocol and all subsequent amendments were approved by the national ethics committee (Ministry of Health, reference N° 2011-12-85) and the institutional ethics committee of the Centre Muraz in Bobo-Dioulasso (reference A24-2010/CE/CM). The National Regulatory authority gave permission to carry out the study. A written informed consent was obtained from all adults and from children’s legal tutors. And additional informed assent forms were signed by adolescent participants (12–18 years). Throughout the study, use of screening and randomization numbers enabled to preserve participants’ personal data confidentiality. The study was registered at the Pan African Clinical Trials Registry under the number PACTR201105000286876.
: Not applicable.
: The authors declare that they have no competing interests.
